Anthony J Musso

US Patent:

20140011829, Jan 9, 2014

Filed:

Jul 6, 2012

Appl. No.:

13/542702

Inventors:

Robert Lewis Steele - Palm Beach Gardens FL, US
Anthony Fedele Musso - West Palm Beach FL, US

International Classification:

A61K 31/4375
A61P 31/14

US Classification:

514280

Abstract:

The present invention describes a method of treating individuals suffering from microbial infections, including a viral infection such as Dengue Fever, using an improved Artemisinin Combination Therapy (ACT), known as Tri-ACT. The improved ACT therapy includes administering a combination of three drugs. In one embodiment of the present invention, the method includes administering to an individual a first composition comprising a therapeutically effective amount of an artemether spray sublingually. The individual is then administered a second composition, a therapeutically effective amount of artesunate. A third composition, an effective amount of berberine, or its pharmaceutically acceptable derivatives or salts is then administered to the individual.

US Patent:

20140256761, Sep 11, 2014

Filed:

Mar 7, 2014

Appl. No.:

14/201740

Inventors:

Robert Lewis Steele - Palm Beach Gardens FL, US
Anthony Fedele Musso - West Palm Beach FL, US
David D. Mundschenk - Hollywood FL, US
Russell Van de Casteele - Pompano Beach FL, US

International Classification:

A61K 31/47
A61K 31/357
A61K 31/4375

US Classification:

514280

Abstract:

The present invention describes a method of treating individuals suffering from microbial infections, including a parasitic disease such as malaria, by using an improved Artemisinin Combination Therapy (ACT), known as ActRx Tri-ACT Plus. The improved ACT therapy includes administering a combination of four drugs. In one embodiment of the present invention, the method includes administering to an individual a first composition comprising a therapeutically effective amount of an artemether spray sublingually. The individual is then administered a second composition, a therapeutically effective amount of artesunate. A third composition, an effective amount of berberine, or its pharmaceutically acceptable derivatives or salts is administered to the individual. A fourth composition, an effective amount of primaquine, or its pharmaceutically acceptable derivatives or salts is administered to the individual.

US Patent:

20140256762, Sep 11, 2014

Filed:

Mar 7, 2014

Appl. No.:

14/201749

Inventors:

Robert Lewis Steele - Palm Beach Gardens FL, US
Anthony Fedele Musso - West Palm Beach FL, US
David D. Mundschenk - Hollywood FL, US
Russell Van de Casteele - Pompano Beach FL, US

International Classification:

A61K 31/4375
A61K 31/357

US Classification:

514280

Abstract:

The present invention describes a method of treating individuals suffering from microbial infections, including a viral infection such as Dengue Fever, using an improved Artemisinin Combination Therapy (ACT), known as Tri-ACT. The improved ACT therapy includes administering a combination of three drugs. In one embodiment of the present invention, the method includes administering to an individual a first composition comprising a therapeutically effective amount of an artemether spray sublingually. The individual is then administered a second composition, a therapeutically effective amount of artesunate. A third composition, an effective amount of berberine, or its pharmaceutically acceptable derivatives or salts is then administered to the individual.